Small
stocks making big moves on Tuesday, March 31, 2015 (as of 4 pm EST), as
reported by Sean Mason, SmallCapPower.com
Microbix Biosystems Inc. (TSX:
MBX) shares climbed 6% to $0.55 on Tuesday after the biological solutions
developer announced that it has entered into a long-term agreement with Minnesota-based
Microbiologics, Inc., pursuant to which Microbix will provide specialized viral
material that will be incorporated into a line of full process controls,
including instrument-specific sets, under Microbiologics’ Helix Elite Molecular
Standards brand.
As well,
shares of MBAC Fertilizer Corp. (TSX:
MBC) plunged 43% to $0.02 on volume of more than 11.2 million shares as the phosphate
fertilizer project developer said it expects that the Ontario Securities
Commission (OSC) will note that the company in default of its continuous
disclosure obligations under Ontario securities laws due it not being in a
position to file its annual audited financial statements for the year ended
December 31, 2014, by the March 31, 2015 regulatory deadline.
Pediapharm Inc. (TSXV:
PDP), meanwhile, reported that it has closed its previously announced
private placement, which the company says gives it the means to execute on the
opportunities in its pipeline consisting of six agreements signed in the last
12 months. Pediapharm is a specialty pharmaceutical company dedicated to
serving the needs of the pediatric community. Its stock popped 48% to $0.34 following
the announcement.
Finally, Theratechnologies Inc. (TSX:
TH) shares gained 3% to $0.98 after the specialty pharmaceutical company announced
that Health Canada has approved a Supplement to a New Drug Submission for the
1mg/vial presentation of EGRIFTA, which the company claims is the only
treatment approved by the U.S. Food and Drug Administration indicated to reduce
excess abdominal fat in HIV-infected patients with lipodystrophy.
